ReviewFrontiers in psychiatry2024

Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen.

Kennadi Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.